View Report Details
Global Blood Plasma Market Report ----------------------------------------2014
View Report Details Executive Summary
Plasma is a composite mixture of more than 700 proteins and other substances which are vital for the smooth functioning of the human body. Plasma is the liquid component of blood, constituting around 50% of the total blood volume. Plasma in itself is approximately 90% water, with the remaining 10% comprising of proteins, minerals, clotting factors, hormones and immunoglobulin which are used for their therapeutic values. With the swift changes and advancement in biomedical/healthcare technology, the healthcare/pharmaceutical/therapeutic industry is becoming ever more competitive. Also, increasing incidences of health related issues owing to changing lifestyles is augmenting the blood plasma industry’s growth. In order to address the rising medical needs related to blood disorders such as autoimmune diseases and liver function impairment among others, market players are coming up with novel and improved treatment options like IVIG, albumin, clotting factors etc. which are derived from human blood plasma. The blood plasma industry is highly regulated to ensure the safety of collected plasma and protect donors. The market is characterized by fast pace developments in the clinical technology and testing methodology. The report, “Global Blood Plasma Market” presents different facets of the global blood plasma market with a focus on sub-markets like IVIG, albumin and hemophilia market. Moreover, market dynamics like the key trends, industry developments, growth drivers and challenges are analyzed in detail. Furthermore, the competitive landscape of the industry is presented. The market remains highly concentrated and is dominated by a handful of players including CSL, Grifols, Baxter and Octapharma. The profiles of these leading players are also included in the report along with their key financials and strategies for growth. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have projected the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.
The global blood plasma market remains on the uptrend driven largely by increasing incidence of bleeding disorders and rising demand from developing economies… Global Blood Plasma Market (2009-2013)
In 2013, global blood plasma market was valued at US$… billion, an increase of …% over 2012.
US$ Billion
The same year saw the immunoglobulin market reaching almost US$ … billion registering a year-on-year growth of … %. In 2013, global hemophilia treatment market remained robust and reached US$… billion growing by …% over 2012 level. Major segments in the Hemophilia market, including Hemophilia A & B and Von Willebrand disease, grew by a CAGR of …% over the five years starting from 2009.
2009
2010
2011
2012
Global demand for Factor VIII and Factor IX increased to ... Billion International Units by an impressive …% over 2012.
2013
Global Immunoglobulin Market (2009-2013)
US$ Billion
US$ Billion
Global Hemophilia Treatment Market (2009-2013E)
2009
2010
2011
2012
2013
2009
2010
2011
2012
2013E
The global plasma industry remains highly influenced by a mixed-bag of factors including both catalysts and inhibitors…
% of Patient Population
Rising Penetration of Episodic Treatment in Emerging Markets (2010-2014E)
Rising demand from the developing world has provided the plasma industry the extra room for growth in light of saturating developed markets. Penetration of episodic treatment in emerging increased from … % in 2011 to …% in 2012 and is estimated to reach …% by the end of 2014. Growth of the global market is further fanned by increasing incidence of bleeding disorders which increased by …% over 2012 to reach … thousand patients in 2013. However, there remains some downside as well with the supply of certain proteins set to exceed demand which is estimated to reach … million International Units by 2015 in the case of FVIII.
2010
2011
2012
2013E
2014E
Also, there has been a consistent rise in the number of plasma collection centers and likewise growth in the fractionation capacity across the globe which will further boost global supplies.
Rising Patient Registration for Hemophilia Treatment (2009-2013E)
Number of Patients
M illion International Units
Excess Supply in FVIII Market (2011-2015E)
2009
2010
2011
2012
2013E
2011
2012
2013E
2014E
2015E
Rising healthcare expenditure, increasing penetration of plasma-derived products, and ageing population are the other chief factors that will drive the market…
US$ Billion
World Blood Plasma Market Forecasts, 2013-2017F
2013
2014F
2015F
2016F
2017F
•
The global blood plasma market is forecasted to grow at a CAGR of ….% and is expected to reach US$... billion by 2017.
•
Rising demand from emerging economies, waning price sensitiveness, an aging population across the OECD member countries, increased consolidation, rising male population and improving global economic conditions are likely to keep the global market buoyant in the medium term,
•
The market will receive a shot in the arm when China would start integrating its domestic blood plasma market with the global market, providing an incredible headroom for future growth.
View Report Contact Us:Details These are abridged and sanitized sample pages from the comprehensive report on the “ Global Blood Plasma Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com